Small molecule discoidin domain receptor kinase inhibitors and potential medical applications

Journal of Medicinal Chemistry

Volumn 58, Issue 8, 2015, Pages 3287-3301

  Li, Yupeng ^a,b   Lu, Xiaoyun ^a   Ren, Xiaomei ^a   Ding, Ke ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYNE DERIVATIVE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BAFETINIB; BOSUTINIB; DASATINIB; DISCOIDIN DOMAIN RECEPTOR KINASE INHIBITOR; IMATINIB; NILOTINIB; PONATINIB; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG; DISCOIDIN RECEPTOR; LECTIN RECEPTOR; LIGAND; MOLECULAR LIBRARY; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE;

ANTIBACTERIAL ACTIVITY; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; INFLAMMATION; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG FIBROSIS; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; ENZYMOLOGY; METABOLISM; MOLECULAR GENETICS; MOLECULAR LIBRARY; NEOPLASMS; PHARMACOLOGY; PROTEIN CONFORMATION;

AMINO ACID SEQUENCE; ANIMALS; DRUG DISCOVERY; HUMANS; INFLAMMATION; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN CONFORMATION; PROTEIN KINASE INHIBITORS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, MITOGEN; SMALL MOLECULE LIBRARIES;

EID: 84928494310     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm5012319     Document Type: Article

References (154)

1. Di Marco, E.; Cutuli, N.; Guerra, L.; Cancedda, R.; De Luca, M. Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues J. Biol. Chem. 1993, 268, 24290-24295
2. Johnson, J. D.; Edman, J. C.; Rutter, W. J. A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 5677-5681
3. Karn, T.; Holtrich, U.; Brauninger, A.; Bohme, B.; Wolf, G.; Rubsamen-Waigmann, H.; Strebhardt, K. Structure, expression and chromosomal mapping of TKT from man and mouse: a new subclass of receptor tyrosine kinases with a factor VIII-like domain Oncogene 1993, 8, 3433-3440
4. Zerlin, M.; Julius, M. A.; Goldfarb, M. NEP: a novel receptor-like tyrosine kinase expressed in proliferating neuroepithelia Oncogene 1993, 8, 2731-2739
5. Lai, C.; Lemke, G. Structure and expression of the Tyro 10 receptor tyrosine kinase Oncogene 1994, 9, 877-883
6. Perez, J. L.; Shen, X.; Finkernagel, S.; Sciorra, L.; Jenkins, N. A.; Gilbert, D. J.; Copeland, N. G.; Wong, T. W. Identification and chromosomal mapping of a receptor tyrosine kinase with a putative phospholipid binding sequence in its ectodomain Oncogene 1994, 9, 211-219
7. Alves, F.; Vogel, W.; Mossie, K.; Millauer, B.; Hofler, H.; Ullrich, A. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer Oncogene 1995, 10, 609-618
8. Shelling, A. N.; Butler, R.; Jones, T.; Laval, S.; Boyle, J. M.; Ganesan, T. S. Localization of an epithelial-specific receptor kinase (EDDR1) to chromosome 6q16 Genomics 1995, 25, 584-587
9. Laval, S.; Butler, R.; Shelling, A. N.; Hanby, A. M.; Poulsom, R.; Ganesan, T. S. Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line Cell Growth Differ. 1994, 5, 1173-1183
10. Perez, J. L.; Jing, S. Q.; Wong, T. W. Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines Oncogene 1996, 12, 1469-1477
11. Playford, M. P.; Butler, R. J.; Wang, X. C.; Katso, R. M.; Cooke, I. E.; Ganesan, T. S. The genomic structure of discoidin receptor tyrosine kinase Genome Res. 1996, 6, 620-627
12. Alves, F.; Saupe, S.; Ledwon, M.; Schaub, F.; Hiddemann, W.; Vogel, W. F. Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: differential expression in human colon cancer cell lines FASEB J. 2001, 15, 1321-1323
13. Shrivastava, A.; Radziejewski, C.; Campbell, E.; Kovac, L.; McGlynn, M.; Ryan, T. E.; Davis, S.; Goldfarb, M. P.; Glass, D. J.; Lemke, G.; Yancopoulos, G. D. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors Mol. Cell 1997, 1, 25-34
14. Vogel, W.; Gish, G. D.; Alves, F.; Pawson, T. The discoidin domain receptor tyrosine kinases are activated by collagen Mol. Cell 1997, 1, 13-23
15. Leitinger, B. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2 J. Biol. Chem. 2003, 278, 16761-16769
16. Leitinger, B.; Steplewski, A.; Fertala, A. The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2 J. Mol. Biol. 2004, 344, 993-1003
17. Leitinger, B.; Kwan, A. P. The discoidin domain receptor DDR2 is a receptor for type X collagen Matrix Biol. 2006, 25, 355-364
18. Agarwal, G.; Mihai, C.; Iscru, D. F. Interaction of discoidin domain receptor 1 with collagen type 1 J. Mol. Biol. 2007, 367, 443-455
19. Xu, H.; Raynal, N.; Stathopoulos, S.; Myllyharju, J.; Farndale, R. W.; Leitinger, B. Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1 Matrix Biol. 2011, 30, 16-26
20. Valiathan, R. R.; Marco, M.; Leitinger, B.; Kleer, C. G.; Fridman, R. Discoidin domain receptor tyrosine kinases: new players in cancer progression Cancer Metast. Rev. 2012, 31, 295-321
21. Vogel, W. F.; Abdulhussein, R.; Ford, C. E. Sensing extracellular matrix: an update on discoidin domain receptor function Cell Signal 2006, 18, 1108-1116
22. Leitinger, B. Discoidin domain receptor functions in physiological and pathological conditions Int. Rev. Cell Mol. Biol. 2014, 310, 39-87
23. Iwai, L. K.; Luczynski, M. T.; Huang, P. H. Discoidin domain receptors: a proteomic portrait Cell. Mol. Life Sci. 2014, 71, 3269-3279
24. Borza, C. M.; Pozzi, A. Discoidin domain receptors in disease Matrix Biol. 2014, 34, 185-192
25. Kothiwale, S.; Borza, C. M.; Lowe, W.; Meiler, J. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery Drug Discovery Today 2014, 10.1016/j.drudis.2014.09.025
26. Kiedzierska, A.; Smietana, K.; Czepczynska, H.; Otlewski, J. Structural similarities and functional diversity of eukaryotic discoidin-like domains Biochim. Biophys. Acta 2007, 1774, 1069-1078
27. Carafoli, F.; Hohenester, E. Collagen recognition and transmembrane signalling by discoidin domain receptors Biochim. Biophys. Acta 2013, 1834, 2187-2194
28. Carafoli, F.; Bihan, D.; Stathopoulos, S.; Konitsiotis, A. D.; Kvansakul, M.; Farndale, R. W.; Leitinger, B.; Hohenester, E. Crystallographic insight into collagen recognition by discoidin domain receptor 2 Structure 2009, 17, 1573-1581
29. Carafoli, F.; Mayer, M. C.; Shiraishi, K.; Pecheva, M. A.; Chan, L. Y.; Nan, R.; Leitinger, B.; Hohenester, E. Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling Structure 2012, 20, 688-697
30. Noordeen, N. A.; Carafoli, F.; Hohenester, E.; Horton, M. A.; Leitinger, B. A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1 J. Biol. Chem. 2006, 281, 22744-22751
31. Mihai, C.; Chotani, M.; Elton, T. S.; Agarwal, G. Mapping of DDR1 distribution and oligomerization on the cell surface by FRET microscopy J. Mol. Biol. 2009, 385, 432-445
32. Lemmon, M. A.; Schlessinger, J. Cell signaling by receptor tyrosine kinases Cell 2010, 141, 1117-1134
33. Lemeer, S.; Bluwstein, A.; Wu, Z.; Leberfinger, J.; Muller, K.; Kramer, K.; Kuster, B. Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1 J. Proteomics 2012, 75, 3465-3477
34. Day, E.; Waters, B.; Spiegel, K.; Alnadaf, T.; Manley, P. W.; Buchdunger, E.; Walker, C.; Jarai, G. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib Eur. J. Pharmacol. 2008, 599, 44-53
35. Canning, P.; Tan, L.; Chu, K.; Lee, S. W.; Gray, N. S.; Bullock, A. N. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors J. Mol. Biol. 2014, 426, 2457-2470
36. Richters, A.; Nguyen, H. D.; Phan, T.; Simard, J. R.; Grütter, C.; Engel, J.; Rauh, D. Identification of type II and III DDR2 inhibitors J. Med. Chem. 2014, 57, 4252-4262
37. Kim, H. G.; Tan, L.; Weisberg, E. L.; Liu, F.; Canning, P.; Choi, H. G.; Ezell, S. A.; Wu, H.; Zhao, Z.; Wang, J.; Mandinova, A.; Griffin, J. D.; Bullock, A. N.; Liu, Q.; Lee, S. W.; Gray, N. S. Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor ACS Chem. Biol. 2013, 8, 2145-2150
38. Ichikawa, O.; Osawa, M.; Nishida, N.; Goshima, N.; Nomura, N.; Shimada, I. Structural basis of the collagen-binding mode of discoidin domain receptor 2 EMBO J. 2007, 26, 4168-4176
39. Leitinger, B. Transmembrane collagen receptors Annu. Rev. Cell Dev. Biol. 2011, 27, 265-290
40. Yeh, Y. C.; Lin, H. H.; Tang, M. J. A tale of two collagen receptors, integrin beta1 and discoidin domain receptor 1, in epithelial cell differentiation Am. J. Physiol-Cell Physiol. 2012, 303, C1207-1217
41. Fu, H. L.; Valiathan, R. R.; Arkwright, R.; Sohail, A.; Mihai, C.; Kumarasiri, M.; Mahasenan, K. V.; Mobashery, S.; Huang, P.; Agarwal, G.; Fridman, R. Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling J. Biol. Chem. 2013, 288, 7430-7437
42. Vogel, W. F.; Aszodi, A.; Alves, F.; Pawson, T. Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development Mol. Cell. Biol. 2001, 21, 2906-2917
43. Faraci-Orf, E.; McFadden, C.; Vogel, W. F. DDR1 signaling is essential to sustain Stat5 function during lactogenesis J. Cell. Biochem. 2006, 97, 109-121
44. Torban, E.; Goodyer, P. The kidney and ear: emerging parallel functions Annu. Rev. Med. 2009, 60, 339-353
45. Meyer zum Gottesberge, A. M.; Gross, O.; Becker-Lendzian, U.; Massing, T.; Vogel, W. F. Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1 Lab Invest. 2008, 88, 27-37
46. Gross, O.; Beirowski, B.; Harvey, S. J.; McFadden, C.; Chen, D.; Tam, S.; Thorner, P. S.; Smyth, N.; Addicks, K.; Bloch, W.; Ninomiya, Y.; Sado, Y.; Weber, M.; Vogel, W. F. DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria Kidney Int. 2004, 66, 102-111
47. Li, S. W.; Prockop, D. J.; Helminen, H.; Fassler, R.; Lapvetelainen, T.; Kiraly, K.; Peltarri, A.; Arokoski, J.; Lui, H.; Arita, M. Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone Genes Dev. 1995, 9, 2821-2830
48. Yang, C.; Li, S. W.; Helminen, H. J.; Khillan, J. S.; Bao, Y.; Prockop, D. J. Apoptosis of chondrocytes in transgenic mice lacking collagen II Exp. Cell Res. 1997, 235, 370-373
49. Labrador, J. P.; Azcoitia, V.; Tuckermann, J.; Lin, C.; Olaso, E.; Manes, S.; Bruckner, K.; Goergen, J. L.; Lemke, G.; Yancopoulos, G.; Angel, P.; Martinez, C.; Klein, R. The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism EMBO Rep. 2001, 2, 446-452
50. Kawai, I.; Matsumura, H.; Fujii, W.; Naito, K.; Kusakabe, K.; Kiso, Y.; Kano, K. Discoidin domain receptor 2 (DDR2) regulates body size and fat metabolism in mice Transgenic Res. 2014, 23, 165-175
51. Borochowitz, Z.; Langer, L. O., Jr.; Gruber, H. E.; Lachman, R.; Katznelson, M. B.; Rimoin, D. L. Spondylo-meta-epiphyseal dysplasia (SMED), short limb-hand type: a congenital familial skeletal dysplasia with distinctive features and histopathology Am. J. Med. Genet. 1993, 45, 320-326
52. Kano, K.; Marin de Evsikova, C.; Young, J.; Wnek, C.; Maddatu, T. P.; Nishina, P. M.; Naggert, J. K. A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse Mol. Endocrinol. 2008, 22, 1866-1880
53. Bargal, R.; Cormier-Daire, V.; Ben-Neriah, Z.; Le Merrer, M.; Sosna, J.; Melki, J.; Zangen, D. H.; Smithson, S. F.; Borochowitz, Z.; Belostotsky, R.; Raas-Rothschild, A. Mutations in DDR2 gene cause SMED with short limbs and abnormal calcifications Am. J. Hum. Genet. 2009, 84, 80-84
54. Ali, B. R.; Xu, H.; Akawi, N. A.; John, A.; Karuvantevida, N. S.; Langer, R.; Al-Gazali, L.; Leitinger, B. Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients Hum. Mol. Genet. 2010, 19, 2239-2250
55. Al-Anbouri, L.; Leitinger, B.; Ali, B. R. A novel mutation in DDR2 causing spondylo-meta-epiphyseal dysplasia with short limbs and abnormal calcifications (SMED-SL) results in defective intra-cellular trafficking BMC Med. Genet. 2014, 15, 42 10.1186/1471-2350-15-42
56. Kamohara, H.; Yamashiro, S.; Galligan, C.; Yoshimura, T. Discoidin domain receptor 1 isoform-a (DDR1a) promotes migration of leukocytes in three-dimensional collagen lattices FASEB J. 2001, 15, 2724-2726
57. Bhatt, R. S.; Tomoda, T.; Fang, Y.; Hatten, M. E. Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons Gene. Dev. 2000, 14, 2216-2222
58. Olaso, E.; Ikeda, K.; Eng, F. J.; Xu, L.; Wang, L. H.; Lin, H. C.; Friedman, S. L. DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells J. Clin. Invest. 2001, 108, 1369-1378
59. Hou, G.; Vogel, W. F.; Bendeck, M. P. Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression Circ. Res. 2002, 90, 1147-1149
60. Ram, R.; Lorente, G.; Nikolich, K.; Urfer, R.; Foehr, E.; Nagavarapu, U. Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2 J. Neuro-Oncol. 2006, 76, 239-248
61. Herrera-Herrera, M. L.; Quezada-Calvillo, R. DDR2 plays a role in fibroblast migration independent of adhesion ligand and collagen activated DDR2 tyrosine kinase Biochem. Bioph. Res. Commun. 2012, 429, 39-44
62. Kawai, I.; Hisaki, T.; Sugiura, K.; Naito, K.; Kano, K. Discoidin domain receptor 2 (DDR2) regulates proliferation of endochondral cells in mice Biochem. Bioph. Res. Commun. 2012, 427, 611-617
63. Kim, D.; You, E.; Min, N. Y.; Lee, K. H.; Kim, H. K.; Rhee, S. Discoidin domain receptor 2 regulates the adhesion of fibroblasts to 3D collagen matrices Int. J. Mol. Med. 2013, 31, 1113-1118
64. Heinzelmann-Schwarz, V. A.; Gardiner-Garden, M.; Henshall, S. M.; Scurry, J.; Scolyer, R. A.; Davies, M. J.; Heinzelmann, M.; Kalish, L. H.; Bali, A.; Kench, J. G.; Edwards, L. S.; Vanden Bergh, P. M.; Hacker, N. F.; Sutherland, R. L.; O'Brien, P. M. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer Clin. Cancer Res. 2004, 10, 4427-4436
65. Quan, J.; Yahata, T.; Adachi, S.; Yoshihara, K.; Tanaka, K. Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer Int. J. Mol. Sci. 2011, 12, 971-982
66. Colas, E.; Perez, C.; Cabrera, S.; Pedrola, N.; Monge, M.; Castellvi, J.; Eyzaguirre, F.; Gregorio, J.; Ruiz, A.; Llaurado, M.; Rigau, M.; Garcia, M.; Ertekin, T.; Montes, M.; Lopez-Lopez, R.; Carreras, R.; Xercavins, J.; Ortega, A.; Maes, T.; Rosell, E.; Doll, A.; Abal, M.; Reventos, J.; Gil-Moreno, A. Molecular markers of endometrial carcinoma detected in uterine aspirates Int. J. Cancer 2011, 129, 2435-2444
67. Yang, S. H.; Baek, H. A.; Lee, H. J.; Park, H. S.; Jang, K. Y.; Kang, M. J.; Lee, D. G.; Lee, Y. C.; Moon, W. S.; Chung, M. J. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas Oncol. Rep. 2010, 24, 311-319
68. Miao, L.; Zhu, S.; Wang, Y.; Li, Y.; Ding, J.; Dai, J.; Cai, H.; Zhang, D.; Song, Y. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition Med. Oncol. 2013, 30, 626
69. Valencia, K.; Ormazabal, C.; Zandueta, C.; Luis-Ravelo, D.; Anton, I.; Pajares, M. J.; Agorreta, J.; Montuenga, L. M.; Martinez-Canarias, S.; Leitinger, B.; Lecanda, F. Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis Clin. Cancer Res. 2012, 18, 969-980
70. Ford, C. E.; Lau, S. K.; Zhu, C. Q.; Andersson, T.; Tsao, M. S.; Vogel, W. F. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma Br. J. Cancer 2007, 96, 808-814
71. Rikova, K.; Guo, A.; Zeng, Q.; Possemato, A.; Yu, J.; Haack, H.; Nardone, J.; Lee, K.; Reeves, C.; Li, Y.; Hu, Y.; Tan, Z.; Stokes, M.; Sullivan, L.; Mitchell, J.; Wetzel, R.; Macneill, J.; Ren, J. M.; Yuan, J.; Bakalarski, C. E.; Villen, J.; Kornhauser, J. M.; Smith, B.; Li, D.; Zhou, X.; Gygi, S. P.; Gu, T. L.; Polakiewicz, R. D.; Rush, J.; Comb, M. J. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer Cell 2007, 131, 1190-1203
72. Barker, K. T.; Martindale, J. E.; Mitchell, P. J.; Kamalati, T.; Page, M. J.; Phippard, D. J.; Dale, T. C.; Gusterson, B. A.; Crompton, M. R. Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours Oncogene 1995, 10, 569-575
73. Turashvili, G.; Bouchal, J.; Baumforth, K.; Wei, W.; Dziechciarkova, M.; Ehrmann, J.; Klein, J.; Fridman, E.; Skarda, J.; Srovnal, J.; Hajduch, M.; Murray, P.; Kolar, Z. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis BMC Cancer 2007, 7, 55
74. Neuhaus, B.; Buhren, S.; Bock, B.; Alves, F.; Vogel, W. F.; Kiefer, F. Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors Cell. Mol. Life Sci. 2011, 68, 3757-3770
75. Weiner, H. L.; Rothman, M.; Miller, D. C.; Ziff, E. B. Pediatric brain tumors express multiple receptor tyrosine kinases including novel cell adhesion kinases Pediatr. Neurosurg. 1996, 25, 64-71
76. Weiner, H. L.; Huang, H.; Zagzag, D.; Boyce, H.; Lichtenbaum, R.; Ziff, E. B. Consistent and selective expression of the discoidin domain receptor-1 tyrosine kinase in human brain tumors Neurosurgery 2000, 47, 1400-1409
77. Yamanaka, R.; Arao, T.; Yajima, N.; Tsuchiya, N.; Homma, J.; Tanaka, R.; Sano, M.; Oide, A.; Sekijima, M.; Nishio, K. Identification of expressed genes characterizing long-term survival in malignant glioma patients Oncogene 2006, 25, 5994-6002
78. Yoshida, D.; Teramoto, A. Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1 J. Neuro-Oncol. 2007, 82, 29-40
79. Squire, J. A.; Bayani, J.; Luk, C.; Unwin, L.; Tokunaga, J.; MacMillan, C.; Irish, J.; Brown, D.; Gullane, P.; Kamel-Reid, S. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: by comparative genomic hybridization, spectral karyotyping, and expression array analysis Head Neck 2002, 24, 874-887
80. Hidalgo-Carcedo, C.; Hooper, S.; Chaudhry, S. I.; Williamson, P.; Harrington, K.; Leitinger, B.; Sahai, E. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6 Nat. Cell Biol. 2011, 13, 49-58
81. Shen, Q.; Cicinnati, V. R.; Zhang, X.; Iacob, S.; Weber, F.; Sotiropoulos, G. C.; Radtke, A.; Lu, M.; Paul, A.; Gerken, G.; Beckebaum, S. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion Mol. Cancer 2010, 9, 227
82. Gu, T. L.; Deng, X.; Huang, F.; Tucker, M.; Crosby, K.; Rimkunas, V.; Wang, Y.; Deng, G.; Zhu, L.; Tan, Z.; Hu, Y.; Wu, C.; Nardone, J.; MacNeill, J.; Ren, J.; Reeves, C.; Innocenti, G.; Norris, B.; Yuan, J.; Yu, J.; Haack, H.; Shen, B.; Peng, C.; Li, H.; Zhou, X.; Liu, X.; Rush, J.; Comb, M. J. Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma PLoS One 2011, 6, e15640
83. Couvelard, A.; Hu, J.; Steers, G.; O'Toole, D.; Sauvanet, A.; Belghiti, J.; Bedossa, P.; Gatter, K.; Ruszniewski, P.; Pezzella, F. Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors Gastroenterol. 2006, 131, 1597-1610
84. Shimada, K.; Nakamura, M.; Ishida, E.; Higuchi, T.; Yamamoto, H.; Tsujikawa, K.; Konishi, N. Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer Cancer Sci. 2008, 99, 39-45
85. Hajdu, M.; Singer, S.; Maki, R. G.; Schwartz, G. K.; Keohan, M. L.; Antonescu, C. R. IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting J. Pathol. 2010, 221, 300-307
86. Chiaretti, S.; Li, X.; Gentleman, R.; Vitale, A.; Wang, K. S.; Mandelli, F.; Foà, R.; Ritz, J. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation Clin. Cancer Res. 2005, 11, 7209-7219
87. Das, S.; Ongusaha, P. P.; Yang, Y. S.; Park, J.-M.; Aaronson, S. A.; Lee, S. W. Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-κB pathway activation Cancer Res. 2006, 66, 8123-8130
88. Miao, L.; Zhu, S.; Wang, Y.; Li, Y.; Ding, J.; Dai, J.; Cai, H.; Zhang, D.; Song, Y. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition Med. Oncol. 2013, 30, 1-9
89. Duncan, J. S.; Whittle, M. C.; Nakamura, K.; Abell, A. N.; Midland, A. A.; Zawistowski, J. S.; Johnson, N. L.; Granger, D. A.; Jordan, N. V.; Darr, D. B.; Usary, J.; Kuan, P. F.; Smalley, D. M.; Major, B.; He, X.; Hoadley, K. A.; Zhou, B.; Sharpless, N. E.; Perou, C. M.; Kim, W. Y.; Gomez, S. M.; Chen, X.; Jin, J.; Frye, S. V.; Earp, H. S.; Graves, L. M.; Johnson, G. L. Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer Cell 2012, 149, 307-321
90. Rodrigues, R.; Roque, L.; Espadinha, C.; Pinto, A.; Domingues, R.; Dinis, J.; Catarino, A.; Pereira, T.; Leite, V. Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas Oncol. Rep. 2007, 18, 917-926
91. Renne, C.; Willenbrock, K.; Kuppers, R.; Hansmann, M. L.; Brauninger, A. Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma Blood 2006, 105, 4051-4059
92. Willenbrock, K.; Kuppers, R.; Renne, C.; Brune, V.; Eckerle, S.; Weidmann, E.; Bräuninger, A.; Hansmann, M. L. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma Haematologica 2006, 91, 596-604
93. Ren, T.; Zhang, J.; Zhang, J.; Liu, X.; Yao, L. Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients Med. Oncol. 2013, 30, 397
94. Ren, T.; Zhang, W.; Liu, X.; Zhao, H.; Zhang, J.; Zhang, J.; Li, X.; Zhang, Y.; Bu, X.; Shi, M.; Yao, L.; Su, J. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia J. Pathol. 2014, 10.1002/path.4415
95. Yan, Z.; Jin, S.; Wei, Z.; Huilian, H.; Zhanhai, Y.; Yue, T.; Juan, L.; Jing, L.; Libo, Y.; Xu, L. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein Biochim. Biophys. Acta 2014, 1842, 1350-1363
96. Xu, J.; Lu, W.; Zhang, S.; Zhu, C.; Ren, T.; Zhu, T.; Zhao, H.; Liu, Y.; Su, J. Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma Cancer Biol. Ther. 2014, 15, 612-622
97. Zhang, K.; Corsa, C. A.; Ponik, S. M.; Prior, J. L.; Piwnica-Worms, D.; Eliceiri, K. W.; Keely, P. J.; Longmore, G. D. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis Nat. Cell Biol. 2013, 15, 677-687
98. Badiola, I.; Villacé, P.; Basaldua, I.; Olaso, E. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells Oncol. Rep. 2011, 26, 971-978
99. Zhang, S.; Bu, X.; Zhao, H.; Yu, J.; Wang, Y.; Li, D.; Zhu, C.; Zhu, T.; Ren, T.; Liu, X.; Yao, L.; Su, J. A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis J. Pathol. 2014, 232, 436-448
100. Ding, L.; Getz, G.; Wheeler, D. A.; Mardis, E. R.; McLellan, M. D.; Cibulskis, K.; Sougnez, C.; Greulich, H.; Muzny, D. M.; Morgan, M. B.; Fulton, L.; Fulton, R. S.; Zhang, Q.; Wend, M. C.; Lawrence, M. S.; Larson, D. E.; Chen, K.; Dooling, D. J.; Sabo, A.; Hawes, A. C.; Shen, H.; Jhangiani, S. N.; Lewis, L. R.; Hall, O.; Zhu, Y.; Mathew, T.; Ren, Y.; Yao, J.; Scherer, S. E.; Clerc, K.; Metcalf, G. A.; Ng, B.; Milosavljevic, A.; Gonzalez-Garay, M. L.; Osborne, J. R.; Meyer, R.; Shi, X.; Tang, Y.; Koboldt, D. C.; Lin, L.; Abbott, R.; Miner, T. L.; Pohl, C.; Fewell, G.; Haipek, C.; Schmidt, H.; Dunford-Shore, B. H.; Kraja, A.; Crosby, S. D.; Sawyer, C. S.; Vickery, T.; Sander, S.; Robinson, J.; Winckler, W.; Baldwin, J.; Chirieac, L. R.; Dutt, A.; Fennell, T.; Hanna, M.; Johnson, B. E.; Onofrio, R. C.; Thomas, R. K.; Tonon, G.; Weir, B. A.; Zhao, X.; Ziaugra, L.; Zody, M. C.; Giordano, T.; Orringer, M. B.; Roth, J. A.; Spitz, M. R.; Wistuba, I. I.; Ozenberger, B.; Good, P. J.; Chang, A. C.; Beer, D. G.; Watson, M. A.; Ladanyi, M.; Broderick, S.; Yoshizawa, A.; Travis, W. D.; Pao, W.; Province, M. A.; Weinstock, G. M.; Varmus, H. E.; Gabriel, S. B.; Lander, E. S.; Gibbs, R. A.; Meyerson, M.; Wilson, R. K. Somatic mutations affect key pathways in lung adenocarcinoma Nature 2008, 455, 1069-1075
101. Davies, H.; Hunter, C.; Smith, R.; Stephens, P.; Greenman, C.; Bignell, G.; Teague, J.; Butler, A.; Edkins, S.; Stevens, C.; Parker, A.; O'Meara, S.; Avis, T.; Barthorpe, S.; Brackenbury, L.; Buck, G.; Clements, J.; Cole, J.; Dicks, E.; Edwards, K.; Forbes, S.; Gorton, M.; Gray, K.; Halliday, K.; Harrison, R.; Hills, K.; Hinton, J.; Jones, D.; Kosmidou, V.; Laman, R.; Lugg, R.; Menzies, A.; Perry, J.; Petty, R.; Raine, K.; Shepherd, R.; Small, A.; Solomon, H.; Stephens, Y.; Tofts, C.; Varian, J.; Webb, A.; West, S.; Widaa, S.; Yates, A.; Brasseur, F.; Cooper, C. S.; Flanagan, A. M.; Green, A.; Knowles, M.; Leung, S. Y.; Looijenga, L. H.; Malkowicz, B.; Pierotti, M. A.; Teh, B. T.; Yuen, S. T.; Lakhani, S. R.; Easton, D. F.; Weber, B. L.; Goldstraw, P.; Nicholson, A. G.; Wooster, R.; Stratton, M. R.; Futreal, P. A. Somatic mutations of the protein kinase gene family in human lung cancer Cancer Res. 2005, 65, 7591-7595
102. Hammerman, P. S.; Sos, M. L.; Ramos, A. H.; Xu, C.; Dutt, A.; Zhou, W.; Brace, L. E.; Woods, B. A.; Lin, W.; Zhang, J.; Deng, X.; Lim, S. M.; Heynck, S.; Peifer, M.; Simard, J. R.; Lawrence, M. S.; Onofrio, R. C.; Salvesen, H. B.; Seidel, D.; Zander, T.; Heuckmann, J. M.; Soltermann, A.; Moch, H.; Koker, M.; Leenders, F.; Gabler, F.; Querings, S.; Ansen, S.; Brambilla, E.; Brambilla, C.; Lorimier, P.; Brustugun, O. T.; Helland, A.; Petersen, I.; Clement, J. H.; Groen, H.; Timens, W.; Sietsma, H.; Stoelben, E.; Wolf, J.; Beer, D. G.; Tsao, M. S.; Hanna, M.; Hatton, C.; Eck, M. J.; Janne, P. A.; Johnson, B. E.; Winckler, W.; Greulich, H.; Bass, A. J.; Cho, J.; Rauh, D.; Gray, N. S.; Wong, K. K.; Haura, E. B.; Thomas, R. K.; Meyerson, M. Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer Cancer Discovery 2011, 1, 78-89
103. Miao, L.; Wang, Y.; Zhu, S.; Shi, M.; Li, Y.; Ding, J.; Yang, J.; Ye, Q.; Cai, H.; Zhang, D.; Liu, H.; Song, Y. Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients BMC Cancer 2014, 24, 369 10.1186/1471-2407-14-369
104. Drilon, A.; Rekhtman, N.; Ladanyi, M.; Paik, P. Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy Lancet Oncol. 2012, 13, e418-426
105. Sos, M. L.; Thomas, R. K. Genetic insight and therapeutic targets in squamous-cell lung cancer Oncogene 2012, 31, 4811-4814
106. Loriaux, M. M.; Levine, R. L.; Tyner, J. W.; Frohling, S.; Scholl, C.; Stoffregen, E. P.; Wernig, G.; Erickson, H.; Eide, C. A.; Berger, R.; Bernard, O. A.; Griffin, J. D.; Stone, R. M.; Lee, B.; Meyerson, M.; Heinrich, M. C.; Deininger, M. W.; Gilliland, D. G.; Druker, B. J. High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia Blood 2008, 111, 4788-4796
107. Tomasson, M. H.; Xiang, Z.; Walgren, R.; Zhao, Y.; Kasai, Y.; Miner, T.; Ries, R. E.; Lubman, O.; Fremont, D. H.; McLellan, M. D.; Payton, J. E.; Westervelt, P.; DiPersio, J. F.; Link, D. C.; Walter, M. J.; Graubert, T. A.; Watson, M.; Baty, J.; Heath, S.; Shannon, W. D.; Nagarajan, R.; Bloomfield, C. D.; Mardis, E. R.; Wilson, R. K.; Ley, T. J. Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia Blood 2008, 111, 4797-4808
108. Pitini, V.; Arrigo, C.; Di Mirto, C.; Mondello, P.; Altavilla, G. Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia Lung Cancer 2013, 82, 171-172
109. Haura, E. B.; Tanvetyanon, T.; Chiappori, A.; Williams, C.; Simon, G.; Antonia, S.; Gray, J.; Litschauer, S.; Tetteh, L.; Neuger, A.; Song, L.; Rawal, B.; Schell, M. J.; Bepler, G. Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer J. Clin. Oncol. 2010, 28, 1387-1394
110. Johnson, F. M.; Bekele, B. N.; Feng, L.; Wistuba, I.; Tang, X. M.; Tran, H. T.; Erasmus, J. J.; Hwang, L. L.; Takebe, N.; Blumenschein, G. R.; Lippman, S. M.; Stewart, D. J. Phase II study of dasatinib in patients with advanced non-small-cell lung cancer J. Clin. Oncol. 2010, 28, 4609-4615
111. Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Sima, C. S.; Ginsberg, M. S.; Pao, W.; Miller, V. A. Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib J. Thorac. Oncol. 2011, 6, 1128-1131
112. Iwai, L. K.; Payne, L. S.; Luczynski, M. T.; Chang, F.; Xu, H.; Clinton, R. W.; Paul, A.; Esposito, E. A.; Gridley, S.; Leitinger, B.; Naegle, K. M.; Huang, P. H. Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants Biochem. J. 2013, 454, 501-513
113. Wall, S. J.; Werner, E.; Werb, Z.; DeClerck, Y. A. Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen J. Biol. Chem. 2005, 280, 40187-40194
114. Yeung, D.; Chmielewski, D.; Mihai, C.; Agarwal, G. Oligomerization of DDR1 ECD affects receptor-ligand binding J. Struct. Biol. 2013, 183, 495-500
115. Fu, H.-L.; Valiathan, R. R.; Payne, L.; Kumarasiri, M.; Mahasenan, K. V.; Mobashery, S.; Huang, P.; Fridman, R. Glycosylation at ASN211 regulates the activation state of the discoidin domain receptor 1 (DDR1) J. Biol. Chem. 2014, 10.1074/jbc.M113.541102
116. Ferri, N.; Carragher, N. O.; Raines, E. W. Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis Am. J. Pathol. 2004, 164, 1575-1585
117. Xu, L.; Peng, H.; Wu, D.; Hu, K.; Goldring, M. B.; Olsen, B. R.; Li, Y. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice J. Biol. Chem. 2005, 280, 548-555
118. Avivi-Green, C.; Singal, M.; Vogel, W. F. Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis Am. J. Resp. Crit. Care 2006, 174, 420-427
119. Gross, O.; Girgert, R.; Beirowski, B.; Kretzler, M.; Kang, H. G.; Kruegel, J.; Miosge, N.; Busse, A. C.; Segerer, S.; Vogel, W. F.; Muller, G. A.; Weber, M. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease Matrix Biol. 2010, 29, 346-356
120. Flamant, M.; Placier, S.; Rodenas, A.; Curat, C. A.; Vogel, W. F.; Chatziantoniou, C.; Dussaule, J. C. Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease J. Am. Soc. Nephrol. 2006, 17, 3374-3381
121. Guerrot, D.; Kerroch, M.; Placier, S.; Vandermeersch, S.; Trivin, C.; Mael-Ainin, M.; Chatziantoniou, C.; Dussaule, J. C. Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy Am. J. Pathol. 2011, 179, 83-91
122. Kerroch, M.; Guerrot, D.; Vandermeersch, S.; Placier, S.; Mesnard, L.; Jouanneau, C.; Rondeau, E.; Ronco, P.; Boffa, J. J.; Chatziantoniou, C.; Dussaule, J. C. Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis FASEB J. 2012, 26, 4079-4091
123. Luo, Z.; Liu, H.; Sun, X.; Guo, R.; Cui, R.; Ma, X.; Yan, M. RNA interference against discoidin domain receptor 2 ameliorates alcoholic liver disease in rats PLoS One 2013, 8, e55860
124. Xu, L.; Servais, J.; Polur, I.; Kim, D.; Lee, P. L.; Chung, K.; Li, Y. Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice Arthritis Rheum. 2010, 62, 2736-2744
125. Lee, J. E.; Kang, C. S.; Guan, X. Y.; Kim, B. T.; Kim, S. H.; Lee, Y. M.; Moon, W. S.; Kim, D. K. Discoidin domain receptor 2 is involved in the activation of bone marrow-derived dendritic cells caused by type I collagen Biochem. Bioph. Res. Commun. 2007, 352, 244-250
126. Poudel, B.; Yoon, D.-S.; Lee, J.-H.; Lee, Y.-M.; Kim, D.-K. Collagen I enhances functional activities of human monocyte-derived dendritic cells via discoidin domain receptor 2 Cell. Immunol. 2012, 278, 95-102
127. Poudel, B.; Ki, H.-H.; Lee, Y.-M.; Kim, D.-K. Induction of IL-12 production by the activation of discoidin domain receptor 2 via NF-κB and JNK pathway Biochem. Bioph. Res. Commun. 2013, 434, 584-588
128. Sun, X.; Phan, T. N.; Jung, S. H.; Kim, S. Y.; Cho, J. U.; Lee, H.; Woo, S. H.; Park, T. K.; Yang, B. S. LCB 03-0110, a novel pan-discoidin domain receptor/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation J. Pharmacol. Exp. Ther. 2012, 340, 510-519
129. Siddiqui, K.; Kim, G. W.; Lee, D. H.; Shin, H. R.; Yang, E. G.; Lee, N. T.; Yang, B. S. Actinomycin D identified as an inhibitor of discoidin domain receptor 2 interaction with collagen through an insect cell based screening of a drug compound library Biol. Pharm. Bull. 2009, 32, 136-141
130. Castro-Sanchez, L.; Soto-Guzman, A.; Navarro-Tito, N.; Martinez-Orozco, R.; Salazar, E. P. Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells Eur. J. Cell. Biol. 2010, 89, 843-852
131. Foehr, E. D.; Tatavos, A.; Tanabe, E.; Raffioni, S.; Goetz, S.; Dimarco, E.; De Luca, M.; Bradshaw, R. A. Discoidin domain receptor 1 (DDR1) signaling in PC12 cells: activation of juxtamembrane domains in PDGFR/DDR/TrkA chimeric receptors FASEB J. 2000, 14, 973-981
132. Ikeda, K.; Wang, L. H.; Torres, R.; Zhao, H.; Olaso, E.; Eng, F. J.; Labrador, P.; Klein, R.; Lovett, D.; Yancopoulos, G. D.; Friedman, S. L.; Lin, H. C. Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen J. Biol. Chem. 2002, 277, 19206-19212
133. Yang, K.; Kim, J. H.; Kim, H. J.; Park, I. S.; Kim, I. Y.; Yang, B. S. Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src stimulates intramolecular autophosphorylation and Shc signaling complex formation J. Biol. Chem. 2005, 280, 39058-39066
134. L'Hote, C. G.; Thomas, P. H.; Ganesan, T. S. Functional analysis of discoidin domain receptor 1: effect of adhesion on DDR1 phosphorylation FASEB J. 2002, 16, 234-236
135. Schenone, S.; Bruno, O.; Radi, M.; Botta, M. New insights into small-molecule inhibitors of Bcr-Abl Med. Res. Rev. 2011, 31, 1-41
136. Lu, X. Y.; Cai, Q.; Ding, K. Recent developments in the third generation inhibitors of Bcr-Abl for overriding T315I mutation Curr. Med. Chem. 2011, 18, 2146-2157
137. Breccia, M.; Alimena, G. How to treat CML patients in the tyrosine kinase inhibitors era? From imatinib standard dose to second generation drugs front-line: Unmet needs, pitfalls and advantages Cancer Lett. 2012, 322, 127-132
138. Ou, S. H. Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence Crit. Rev. Oncol. Hemat. 2012, 83, 407-421
139. Yang, X. W.; Yang, K.; Kuang, K. Y. The efficacy and safety of EGFR inhibitor monotherapy in non-small cell lung cancer: a systematic review Curr. Oncol. Rep. 2014, 16, 390
140. Lou, Y.; Owens, T. D.; Kuglstatter, A.; Kondru, R. K.; Goldstein, D. M. Bruton's tyrosine kinase inhibitors: approaches to potent and selective inhibition, preclinical and clinical evaluation for inflammatory diseases and B cell malignancies J. Med. Chem. 2012, 55, 4539-4550
141. Davis, M. I.; Hunt, J. P.; Herrgard, S.; Ciceri, P.; Wodicka, L. M.; Pallares, G.; Hocker, M.; Treiber, D. K.; Zarrinkar, P. P. Comprehensive analysis of kinase inhibitor selectivity Nat. Biotechnol. 2011, 29, 1046-1051
142. Gao, M.; Duan, L.; Luo, J.; Zhang, L.; Lu, X.; Zhang, Y.; Zhang, Z.; Tu, Z.; Xu, Y.; Ren, X.; Ding, K. Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors J. Med. Chem. 2013, 56, 3281-3295
143. Rix, U.; Hantschel, O.; Durnberger, G.; Remsing Rix, L. L.; Planyavsky, M.; Fernbach, N. V.; Kaupe, I.; Bennett, K. L.; Valent, P.; Colinge, J.; Kocher, T.; Superti-Furga, G. Chemical proteomic profiles of the Bcr-Abl inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets Blood 2007, 110, 4055-4063
144. Li, J.; Rix, U.; Fang, B.; Bai, Y.; Edwards, A.; Colinge, J.; Bennett, K. L.; Gao, J.; Song, L.; Eschrich, S.; Superti-Furga, G.; Koomen, J.; Haura, E. B. A chemical and phosphoproteomic characterization of dasatinib action in lung cancer Nat. Chem. Biol. 2010, 6, 291-299
145. Bantscheff, M.; Eberhard, D.; Abraham, Y.; Bastuck, S.; Boesche, M.; Hobson, S.; Mathieson, T.; Perrin, J.; Raida, M.; Rau, C.; Reader, V.; Sweetman, G.; Bauer, A.; Bouwmeester, T.; Hopf, C.; Kruse, U.; Neubauer, G.; Ramsden, N.; Rick, J.; Kuster, B.; Drewes, G. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors Nat. Biotechnol. 2007, 25, 1035-1044
146. Rix, U.; Remsing Rix, L. L.; Terker, A. S.; Fernbach, N. V.; Hantschel, O.; Planyavsky, M.; Breitwieser, F. P.; Herrmann, H.; Colinge, J.; Bennett, K. L.; Augustin, M.; Till, J. H.; Heinrich, M. C.; Valent, P.; Superti-Furga, G. A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells Leukemia 2010, 24, 44-50
147. Ren, X.; Pan, X.; Zhang, Z.; Wang, D.; Lu, X.; Li, Y.; Wen, D.; Long, H.; Luo, J.; Feng, Y.; Zhuang, X.; Zhang, F.; Liu, J.; Leng, F.; Lang, X.; Bai, Y.; She, M.; Tu, Z.; Pan, J.; Ding, K. Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinib J. Med. Chem. 2013, 56, 879-894
148. For more information about this assay, see www.discoverx.com.
149. Beauchamp, E. M.; Woods, B. A.; Dulak, A. M.; Tan, L.; Xu, C.; Gray, N. S.; Bass, A. J.; Wong, K. K.; Meyerson, M.; Hammerman, P. S. Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss Mol. Cancer. Ther. 2013, 13, 475-482
150. Takeshi, M.; Satoshi, N.; Sousuke, H.; Hatsuo, K.; Kihito, H.; Hideaki, S.; Hiroshi, T.; Yoshito, N. Benzamide derivative. WO2013161851, 2013.
151. Takeshi, M.; Hatsuo, K.; Satoshi, N.; Sousuke, H.; Kihito, H.; Hideaki, S.; Hiroshi, T.; Toshiyuki, M. Quinazolinedione derivative. WO2013161853, 2013.
152. Wucherer-Plietker, M.; Werkmann, D.; Gigout, A.; Kuhn, D.; Sawatzky, E. New substituted aryl compounds are discoidin domain receptor tyrosine kinase 2 inhibitors used to treat e.g. osteoarthritis, hepatocirrhosis, traumatic cartilage injuries, allodynia, hyperalgesia, Alzheimer's disease, scarring and rickets. WO2014032755, 2014.
153. Hu, Y.; Potts, M. B.; Colosimo, D.; Herrera-Herrera, M. L.; Legako, A. G.; Yousufuddin, M.; White, M. A.; MacMillan, J. B.; Discoipyrroles, A.-D. isolation, structure determination, and synthesis of potent migration inhibitors from Bacillus hunanensis J. Am. Chem. Soc. 2013, 135, 13387-13392
154. Aguilera, K. Y.; Goldstein, C. D.; Bradshaw, A. D.; Ding, K.; Brekken, R. A., SPARC as a regulator of collagen signaling in pancreatic cancer. Program Book, ASMB 2014 Biennial Meeting, Cleveland, OH, Oct 12-15, 2014; ASMB: Bethesda, MD, 2014; Abstract 137.